A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 575,000 shares of ORIC stock, worth $4.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
575,000
Previous 780,400 26.32%
Holding current value
$4.89 Million
Previous $5.52 Million 6.82%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $11.9 $1.54 Million - $2.44 Million
-205,400 Reduced 26.32%
575,000 $5.89 Million
Q2 2024

Aug 14, 2024

SELL
$6.63 - $12.93 $1.66 Million - $3.23 Million
-250,000 Reduced 24.26%
780,400 $5.52 Million
Q1 2024

May 15, 2024

BUY
$8.04 - $16.03 $8.28 Million - $16.5 Million
1,030,400 New
1,030,400 $14.2 Million

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.